Drawing for CSA

USPTO serial 77018446

CSA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SERVANCE, RENEE L
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CSA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sarah Anne Keefe

Sarah Anne Keefe Womble Calyle Sandridge & Rice PLLC150 Fayetteville Street, Suite 2100Raleigh, NC 27601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Video monitors, computers for controlling cryoptherapy and cryosurgery devices and cryoptherapy delivery systems and printersABANDONED—
010Cryosurgical apparatus for use in performing ablative surgery; medical devices, namely cryoptherapy and cryosurgical devices, namely, surgical and treatment probes, catheters and endoscopes; cryosurgical and cryoptherapy device control systems, namely, apparatuses for controlling the flow of cryogens, bleeder and pressure reduction valves for maintaining pressure in cryoptherapy and cryosurgical devices and delivery systems, rigid and flexible medical endoscopes, catheters, lumen blocking balloons and shields for gastric blocking, nasogastric tubes, suction devices for cryogens removal and endoscopy cameras; cryosurgical tools or units used to destroy tissue during surgical procedures, namely catheters for the introduction of a cryogen to a target tissue; and therapy and surgical delivery systems and components thereof for delivering cryogens to a patient, namely surgical and treatment probes, catheters and endoscopesABANDONED—
041Training of physicians and medical personnel in the use of cryoptherapy and cryosurgery; training of physicians and medical personnel in the use of cryoptherapy and cryosurgical equipment, namely surgical and treatment probes, catheters and endoscopes; training of physicians and medical personnel in the use of cryosurgical and cryoptherapy device control systems, namely, apparatuses for controlling the flow of cryogens, bleeder and pressure reduction valves for maintaining pressure in cryoptherapy and cryosurgical devices and delivery systems, rigid and flexible medical endoscopes, catheters, lumen blocking balloons and shields for gastric blocking, nasogastric tubes, suction devices for cryogens removal and endoscopy cameras; training of physicians and medical personnel in the use of therapy and surgical delivery systems for delivering cryogens, namely rigid and flexible medical endoscopes, catheters, lumen blocking balloons and shields for gastric blocking, nasogastnc tubes, suction devices for cryogens removal and endoscopy cameras; training of physicians and medical personnel in performing medical procedures involving cryoptherapy and cryosurgery; and training of physicians and medical personnel in performing medical procedures involving abdominal, bladder, pancreatic, kidney, lung, stomach, esophageal and upper and lower gastrointestinal tissue identification, separation, ablation or eradicationABANDONED—
044Medical procedures, namely performing cryoptherapy and cryosurgery; performing medical procedures involving abdominal, bladder, pancreatic, kidney, lung, stomach, esophageal, upper and lower gastrointestinal tissue identification, separation, ablation or eradication of unwanted lesions using endoscopic surgeryABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 23, 2010OP.DOPPOSITION DISMISSED NO. 999999—
Jan 14, 2010MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Jan 14, 2010ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Jan 14, 2010OP.TOPPOSITION TERMINATED NO. 999999—
Jan 14, 2010OP.DOPPOSITION DISMISSED NO. 999999—
May 6, 2009ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 1, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 1, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 21, 2008OP.IOPPOSITION INSTITUTED NO. 999999—
Oct 22, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 22, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 15, 2007ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 25, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 5, 2007NPUBNOTICE OF PUBLICATION—
Aug 17, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 17, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Aug 17, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 1, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Aug 1, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 30, 2007MAILPAPER RECEIVED—
May 22, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 2, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
May 2, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 2, 2007ALIEASSIGNED TO LIE—
Apr 4, 2007MAILPAPER RECEIVED—
Mar 2, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2007DOCKASSIGNED TO EXAMINER—
Dec 21, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 16, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance